BU-NOT-SET

CONTACT US
Overcoming the challenges surrounding manufacturing oncolytic viruses
  • Biologics
Virus
Insight
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain
  • Drug product
  • Industry trends
DCAT insights
Insight
Developing a robust dissolution method for low-dose formulations
  • Analytical chemistry
  • Drug product
low-dose formulation
White paper
Sustainability report 2022
  • Sustainability
Sustainability report 2022
Report
Navigating the changing oral solid dose landscape
  • Drug product
  • Industry trends
Oral solid dose
Insight
The opportunities and obstacles of filling and packaging pre-filled syringes
  • Drug product
  • Manufacturing
pre-filled syringes
Insight
Tips for facilitating a successful tech transfer between sponsor and CDMO
  • Drug product
  • Industry trends
Tech transfer
Insight
Alternative drug delivery formulation & device expertise
  • Drug product
  • Industry trends
Industry trends
Insight
The 3 key trends shaping the CDMO industry in 2023 and beyond
  • Industry trends
CDMO trends
Insight
Insight
  • Biologics
ReciBioPharm Is Advancing xRNA Production
eBook
  • Drug product
  • Manufacturing
Navigating the complexities of pre-filled syringes for biologics
Insight
  • Drug product
  • Manufacturing
Unlocking the potential of mRNA with robust lyophilisation strategies
Insight
  • Biologics
Advanced Bio Is Advancing AAV Production
Insight
  • Biologics
Advanced is advancing xRNA manufacturing
Insight
  • Drug product
  • Manufacturing
What are the innovations driving the future of sterile drug packaging?
Insight
  • Biologics
Revolutionising gene editing with end-to-end CDMO services
Insight
  • Biologics
Advanced Bio streamlines regulatory compliance
Insight
  • Biologics
Advanced Bio leads nucleic acid innovation